GlassScriptPhysician profile
Mohammed Touheed
NPI 1700868809
$253.21
in general payments reported to CMS, 2019-2025
7 companies · $22.83 in 2025
The $22.83 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $122 · 2024: $108 · 2025: $22.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $122.40 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $33.48 | 2024 | Spravato |
| Corcept Therapeutics | $22.83 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $21.37 | 2024 | Trelegy Ellipta |
| Novo Nordisk INC | $18.51 | 2024 | Ozempic, Rybelsus |
| Inspire Medical Systems, INC. | $17.65 | 2024 | Inspire |
| Astellas Pharma US INC | $16.97 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Touheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.